1,115 Shares in Encompass Health Co. (NYSE:EHC) Acquired by Centaurus Financial Inc.

Centaurus Financial Inc. bought a new stake in Encompass Health Co. (NYSE:EHC) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 1,115 shares of the company’s stock, valued at approximately $108,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. UMB Bank n.a. increased its holdings in shares of Encompass Health by 387.7% in the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company’s stock worth $31,000 after acquiring an additional 252 shares during the period. V Square Quantitative Management LLC increased its position in shares of Encompass Health by 53.0% in the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock worth $39,000 after acquiring an additional 140 shares in the last quarter. Avior Wealth Management LLC purchased a new position in shares of Encompass Health in the third quarter worth approximately $40,000. Oakworth Capital Inc. purchased a new position in shares of Encompass Health in the second quarter worth approximately $40,000. Finally, Benjamin F. Edwards & Company Inc. increased its position in shares of Encompass Health by 58.9% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company’s stock worth $46,000 after acquiring an additional 198 shares in the last quarter. 97.25% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on the stock. Truist Financial reaffirmed a “buy” rating and set a $116.00 price objective (up from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. KeyCorp boosted their price target on shares of Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a report on Tuesday, October 29th. Barclays upped their target price on shares of Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. Stephens reiterated an “overweight” rating and set a $105.00 price target on shares of Encompass Health in a research report on Tuesday, August 6th. Finally, UBS Group upped their price target on shares of Encompass Health from $100.00 to $110.00 and gave the stock a “buy” rating in a research report on Wednesday, September 25th. Nine research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average target price of $107.11.

Encompass Health Trading Down 0.9 %

NYSE EHC opened at $102.84 on Friday. The company has a market cap of $10.36 billion, a PE ratio of 24.84, a PEG ratio of 1.35 and a beta of 0.88. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88. Encompass Health Co. has a 12 month low of $63.78 and a 12 month high of $104.55. The stock has a 50 day moving average of $97.74 and a 200-day moving average of $91.19.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Monday, October 28th. The company reported $1.03 EPS for the quarter, beating the consensus estimate of $0.94 by $0.09. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The company had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.33 billion. During the same quarter in the prior year, the firm posted $0.86 EPS. The firm’s revenue for the quarter was up 11.9% compared to the same quarter last year. On average, equities research analysts anticipate that Encompass Health Co. will post 4.29 EPS for the current fiscal year.

Encompass Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be issued a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 0.66%. The ex-dividend date of this dividend is Thursday, January 2nd. Encompass Health’s dividend payout ratio is 16.43%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.